Search

In this new paper in Virus Evolution, Eric Olo Ndela (Université Clermont Auvergne, France) and colleagues report the discovery of sixteen complete microvirus genomes that represent two novel groups of microviruses, tentatively named Reekee

In a new paper in Cell, Brianna Duncan-Lowey (Harvard Medical School) and colleagues determined the cryo-EM structures of the RADAR defense complex, revealing RdrA as a heptameric, two-layered AAA+ ATPase and RdrB as a dodecameric, hollow c

A new paper by Pablo Quirós (Universitat de Barcelona) and colleagues published in The ISME Journal reports the isolation of the first phage infecting some Nitrosomonas species. This polyvalent virulent phage (named ΦNF-1) infected Nitrosom

Soo Khim Chan (University of California San Diego) and colleagues have developed peptides which bind specifically to Pseudomonas phage Good Vibes, which may enable real-time analysis of phage in vivo and monitor the efficacy of phage therap

In a new paper in Biotechnology Advances, Wajid Hussain (Huazhong University of Science and Technology) and colleagues review genetic engineering approaches for bacteriophages, with a focus on their potential applications.

On Feb 28 at 5PM East Africa Time, Phage Kenya Consortium will be hosting a talk by Dr. Evelien Adriaenssens (Quadram Institute; Chair of ICTV Bacterial Viruses Committee) on the recently announced changes to phage taxonomy, including the a

On February 8 at 9:30am GMT the UK Parliament Science and Technology Committee will be holding a public oral evidence session for "The antimicrobial potential of bacteriophages."

The MDPI Journal 'Cells' is hosting a special issue entitled Phage Therapy and Phage-Derived Enzymes as Antibacterial Agents led by Guest Editors Drs. Stephen Abedon, Katarzyna Danis-Wlodarczyk, Razi Kebriaei, and Aleksandra Petrovic Fabija

Researchers from UC San Diego, the J. Craig Venter Institute and Yale University have been awarded $10 million by the Howard Hughes Medical Institute (HHMI) to support research on using jumbo viruses as new therapeutic agents.

In this new paper in Frontiers in Microbiology, Qin Qi (Macquarie University, Australia) and colleagues present evidence that temperate and virulent (lytic) bacteriophages (phages) carry integrons. Integrons are mobile genetic elements that

In a new paper in PNAS, Benoit Pons (University of Exeter) and colleagues show that antibiotics that target the protein translation machinery can alter the outcome of bacteria-phage interactions by interfering with the production of phage-e

A new paper by Jan Finke (Hakai Institute, Canada) and colleagues describes Deep6, a deep learning model for classification of metatranscriptomic sequences into prokaryotes, eukaryotes, or one of the four viral realms (Duplodnaviria, Varidn

Daniela Rothschild-Rodriguez and colleagues published a new paper exploring the role of phages in influencing the mucosal integrity of the human gut, and how these interactions may affect health and disease states. They also cover phage-enc

In the latest episode of the Phage Therapy Today podcast, Carrie-Lynn Langlais Furr, CEO and Co-founder at Bacteriophage & Drug Development Consultants (BDDC) talks about how to navigate the drug development and regulatory waters for phage

The next Viruses of Microbes conference will be held in Tbilisi, Georgia on July 3-7, 2023. The conference marks a new era in viral research which has begun with the recognition of viruses of microorganisms – viruses of bacteria, archaea, a

In this PBS Vitals video, Alok Patel (MD) and Sheena Williams (RN) explore how phage therapy could help humanity win the battle against antibiotic-resistant superbugs.

Vésale Bioscience, a Belgian phage therapy company, has been awarded a €1.8m grant from the European Innovation Council to develop a phage therapy diagnostic platform to fight multidrug-resistant infections.

Adaptive Phage Therapeutics announced that the first patient has been dosed in the PHAGE clinical trial, evaluating bacteriophage therapy in adults with cystic fibrosis who carry Pseudomonas aeruginosa in their lungs.

Ben Chan (Center for Phage Biology & Therapy, Yale University) and colleagues report the use of a personalized, inhaled phage therapy for treating P. aeruginosa infections in 9 CF adults, with the goal of selecting phages that target bacter

Ellina Trofimova has developed a new version of her Plaque Size Tool that doesn't require installation on Google Colab.